Author

V. Ravi Kumar

Central Drug Research InstituteORCID 0000-0003-4540-2815Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

V. Ravi Kumar2 papers

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Bushra QaziiD· 1 shared Garima Pant· 1 shared Kalyan MitraiD· 1 shared Kamal Tripathi Raj· 1 shared Prabu ParamasivamiD· 1 shared Raj Kamal TripathiiD· 1 shared Ram Murugesan· 1 shared Ramakrishnan RamakrishnaniD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Bushra QaziORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintMay 4, 2026

Host cell plasma membrane-derived vesicles efficiently inhibit in vitro Influenza A virus infection in a size-dependent manner

Bushra Qazi, Vaishali Vishwakarma, V. Ravi Kumar…·Sourav Haldar

This study shows that plasma membrane-derived vesicles inhibit Influenza A virus infection in a size-dependent manner by competitively binding to hemagglutinin.

DOI 10.64898/2026.05.03.722494

humanexperimental assay

𝕏 PostBluesky

Systems BiologybioRxivPreprintApr 20, 2020

Interplay of host regulatory network on SARS-CoV-2 binding and replication machinery

Shiek S. S. J. Ahmed, Prabu Paramasivam, Kamal Tripathi Raj…·Ramakrishnan Ramakrishnan

The paper investigates the host regulatory network's role in SARS-CoV-2 binding and replication, identifying key hubs and miRNAs that could be therapeutic targets.

6 citations

humanproteomics

𝕏 PostBluesky